Immediate Impact

1 by Nobel laureates 1 from Science/Nature 69 standout
Sub-graph 1 of 22

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
2023 Standout
5 intermediate papers

Works of S. Gouva being referenced

Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer
2005
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
S. Gouva 324 334 42 85 24 448
Harald Dörr 145 71 115 21 18 466
E. Cederquist 85 101 33 7 17 482
Angela Botticella 228 260 31 24 36 373
Mathias Haenel 58 262 62 126 35 495
Anatoly F. Tsyb 29 107 149 15 17 482
Makoto Fukuoka 38 65 79 13 31 409
Margarita Amenedo 192 291 44 6 42 388
Richard E. Ottoman 78 72 105 17 22 402
Ayşe Nur Demiral 190 135 64 32 28 384
Marita Mariotti 317 228 134 13 26 477

All Works

Loading papers...

Rankless by CCL
2026